EE340 Cost-Effectiveness Analysis of Molnupiravir Against Standard Care for Treating Mild to Moderate COVID-19 Infection in Singapore.
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.606
https://www.valueinhealthjournal.com/article/S1098-3015(23)03736-1/fulltext
Title :
EE340 Cost-Effectiveness Analysis of Molnupiravir Against Standard Care for Treating Mild to Moderate COVID-19 Infection in Singapore.
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03736-1&doi=10.1016/j.jval.2023.09.606
First page :
Section Title :
Open access? :
No
Section Order :
10095